Lykos, a general public gain business, was shaped in 2014 as an offshoot in the Multidisciplinary Association for Psychedelic Scientific tests, a nonprofit which has invested much more than $150 million into psychedelic research and advocacy.Success from two controlled clinical trials of the results of psilocybin on people managing melancholy and d